Sankala Group’s Cardinal Health CAH Stock Holding History

Sankala Group’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5	Closed	-$1.2K	–	523
2026 Q2	$1.2K	Hold	5	–	–	﹤0.01%	541
2026 Q1	$1.05K	Hold	5	–	–	﹤0.01%	525
2025 Q4	$1.16K	Buy	+5	New	+$941	﹤0.01%	530

Other funds holding CAH

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Sankala Group's CAH Position: Q3 2026 in Review

Sankala Group sold out of Cardinal Health (CAH) in Q3 2026, closing a stake of 5 shares — an estimated $1.2K sold.

Sankala Group first reported a position in CAH in Q4 2025 and held it in 3 quarters. The position peaked at $1.2K in Q2 2026. 859 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

Sankala Group reported no remaining Cardinal Health position as of Q3 2026 after selling out during the quarter.
Sankala Group sold 5 Cardinal Health shares in Q3 2026, an estimated $1.2K.
Sankala Group first reported a position in Cardinal Health in Q4 2025 and held it in 3 quarters.
Sankala Group's Cardinal Health position peaked at $1.2K in Q2 2026.
859 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.